Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies

Ariella Glasner, Samuel A. Rose, Roshan Sharma, Herman Gudjonson, Tinyi Chu, Jesse A. Green, Sham Rampersaud, Izabella K. Valdez, Emma S. Andretta, Bahawar S. Dhillon, Michail Schizas, Stanislav Dikiy, Alejandra Mendoza, Wei Hu, Zhong-Min Wang, Ojasvi Chaudhary, Tianhao Xu, Linas Mazutis, Gabrielle Rizzuto, Alvaro Quintanal-Villalonga, Parvathy Manoj, Elisa de Stanchina, Charles M. Rudin, Dana Pe’er, Alexander Y. Rudensky

Abstract

While regulatory T (Treg) cells are traditionally viewed as professional suppressors of antigen presenting cells and effector T cells in both autoimmunity and cancer, recent findings of distinct Treg cell functions in tissue maintenance suggest that their regulatory purview extends to a wider range of cells and is broader than previously assumed. To elucidate tumoral Treg cell ‘connectivity’ to diverse tumor-supporting accessory cell types, we explored immediate early changes in their single-cell transcriptomes upon punctual Treg cell depletion in experimental lung cancer and injury-induced inflammation. Before any notable T cell activation and inflammation, fibroblasts, endothelial and myeloid cells exhibited pronounced changes in their gene expression in both cancer and injury settings. Factor analysis revealed shared Treg cell-dependent gene programs, foremost, prominent upregulation of VEGF and CCR2 signaling-related genes upon Treg cell deprivation in either setting, as well as in Treg cell-poor versus Treg cell-rich human lung adenocarcinomas. Accordingly, punctual Treg cell depletion combined with short-term VEGF blockade showed markedly improved control of PD-1 blockade-resistant lung adenocarcinoma progression in mice compared to the corresponding monotherapies, highlighting a promising factor-based querying approach to elucidating new rational combination treatments of solid organ cancers.

Datasets

1. Transcriptional connectivity of regulatory T cells in the tumor microenvironment informs novel combination cancer therapy strategies
Metadata
sample_name
Procedure_Type
Phenograph_cluster
histology
sample_number
hta_id
Gender
Ethnicity
Race
Smoking Status
Stage at Dx
Tissue Type
ProcedureType
Treatment Status
Tissue Site
hta_donor_id
cell_lineage
assay_ontology_term_id
sex_ontology_term_id
self_reported_ethnicity_ontology_term_id
cell_type_ontology_term_id
donor_id
development_stage_ontology_term_id
organism_ontology_term_id
disease_ontology_term_id
suspension_type
tissue_ontology_term_id
tissue_type
cell_type
assay
disease
organism
sex
tissue
self_reported_ethnicity
development_stage
Ru1426B_T_112405 cells
Ru222b_T_17865 cells
Ru1477a_T_14423 cells
RU684_TUMOR4275 cells
RU10274222 cells
RU661_TUMOR4160 cells
RU682_TUMOR3847 cells
1262C3795 cells
Ru1419b_T_23759 cells
RU676_TUMOR3665 cells
Ru1134_Freeze_thaw3161 cells
Ru1080b_T_2_re3020 cells
RU675_TUMOR3000 cells
RU1057_Tumor_Mix2900 cells
RU653_TUMOR2717 cells
Ru1134-CN22481 cells
Ru1170g2136 cells
Ru11371995 cells
Ru13781907 cells
Ru1038_Plus_frozen1898 cells
Ru11351678 cells
Ru1330B_T_11645 cells
Ru1134b_T_21009 cells
Ru679B_T_t2_1579 cells
Ru1271449 cells
Preview
Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies

Analyze this study

Source data

https://cellxgene.cziscience.com/collections/efd94500-1fdc-4e28-9e9f-a309d0154e21

Alias names

HTAN MSK, phs002371, PMID37127830, PMC10232368

Cite this study

Glasner, A., Rose, S.A., Sharma, R., Gudjonson, H., Chu, T., Green, J.A., Rampersaud, S., Valdez, I.K., Andretta, E.S., Dhillon, B.S. and Schizas, M., 2023. Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies. Nature immunology, 24(6), pp.1020-1035. https://doi.org/10.1038/s41590-023-01504-2